BioMarin Pharmaceutical: BioMarin Pharmaceutical develops and commercializes therapies for rare genetic diseases.
⚠️ This profile was automatically generated by the AYA bot. Information may be inaccurate. Claim this profile to correct and certify your data.
Identification
Current Status
● INDEXED
AIO Score (AI Readability)
50/100* This score measures how readable the company is by AIs (ChatGPT, Gemini, Claude...). The higher the score, the more visible and recommendable the company is.
Public Key (AYA ID)
d0336f5b-7f0b-543f-a66b-0ce07779886b
Issue date
25 mars 2026
Validity
—
Last modified: 25 mars 2026
Semantic Data (AI)
"BioMarin Pharmaceutical develops and commercializes therapies for rare genetic diseases."
Indexed Keywords
#rare genetic diseases#orphan drugs#biopharmaceuticals#enzyme replacement therapy#clinical trials#genetics#personalized medicine#drug development
Supported Protocols
- ✓ JSON-LD Structure
- ✓ ASR v3.0 Standard
Secured by AYO Consensus • Swiss Hosting